文献速递儿童青少年精神

RVG工程化细胞外囊泡递送miR-137通过调节糖代谢与神经炎症改善自闭症

RVG engineered extracellular vesicles-transmitted miR-137 improves autism by modulating glucose metabolism and neuroinflammation.
PubMed 文献 · Mol Psychiatry · 2025-04-02

该研究在ASD患者外周血及BTBR小鼠血清和小脑中检测到miR-137降低,并发现BTBR小鼠小胶质细胞活化、乳酸及糖酵解关键酶升高。RVG工程化EVs递送miR-137靶向脑内,经尾静脉给药抑制TLR4/NF-κB通路、减少HIF-1α及糖酵解酶转录,减轻神经炎症和自闭症样行为。

要点

  • ASD患者外周血及BTBR小鼠血清和小脑中miR-137表达降低。
  • RVG-miR137-EVs经尾静脉给药可靶向脑内并改善BTBR小鼠自闭症样行为。
  • miR-137通过靶向TLR4抑制NF-κB/HIF-1α通路,下调糖酵解关键酶。

核心结论

  • miR-137可通过HIF-1α介导的糖酵解适应性代谢改变和神经炎症减轻自闭症样行为。

研究设计与样本

  • 研究检测了ASD患者外周血及BTBR小鼠血清和小脑中miR-137水平,并在BTBR小鼠中评估RVG工程化EVs递送miR-137的效果。

主要发现

  • ASD患者外周血和BTBR小鼠血清及小脑中miR-137降低。
  • BTBR小鼠小胶质细胞活化,乳酸及糖酵解关键酶HK2、PKM2和LDHA显著升高。
  • RVG-miR137-EVs经尾静脉给药靶向脑内,抑制BTBR小鼠促炎活化并减少乳酸生成,改善自闭症样行为。
  • miR-137靶向TLR4抑制TLR4/NF-κB通路,降低HIF-1α并抑制HK2、PKM2和LDHA转录。
  • 药理学抑制糖酵解和TLR4可减轻小胶质细胞活化及乳酸生成,改善BTBR小鼠自闭症样行为。

临床怎么用

  • RVG工程化EVs递送miR-137可能为ASD提供靶向脑内糖代谢与神经炎症的干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder. The microglia activation is a hallmark of ASD, which involves increased glycolysis. Elevated glycolysis regardless of oxygen availability, known as "Warburg effect", is crucial to pathogenesis in neuropsychiatric disorders. Psychiatric risk gene MIR137 plays an important role in neurogenesis and neuronal maturation, but the impact on neuroinflammation and glucose metabolism remains obscure. Extracellular vesicles (EVs) can delivery miR-137 crossing the blood-brain barrier. Meanwhile, EVs can help miR-137 avoid being rapidly degraded by endogenous nucleases. Here, after first detecting miR-137 decreased both in the peripheral blood of individuals with ASD and the serum and cerebellum of BTBR mice, we demonstrated that microglia activation, the level of lactate and key enzymes (HK2, PKM2 and LDHA) involved in glycolysis were increased significantly in BTBR mice. Of particular note, EVs engineered by rabies virus glycoprotein (RVG) could promote the miR-137 (RVG-miR137-EVs) targeted to the brain accurately, and alleviated autism-like behaviors. Pro-inflammatory activation of BTBR mice was considerably inhibited by RVG-miR137-EVs via tail vein administration, accompanied by decreased lactate production. Mechanically, these effects were attributed to TLR4, the key target gene, which was regulated by miR-137. The TLR4/NF-κB pathway was inhibited, subsequently reducing HIF-1α and repressing the transcription of HK2, PKM2 and LDHA involved in glycolysis. Pharmacological inhibition of glycolysis and TLR4 attenuated microglial activation and lactate production, ultimately improved autism-like behaviors of BTBR mice. In conclusion, our results indicated that miR-137 could alleviate autism-like behaviors by HIF-1α-mediated adaptive metabolic changes in glycolysis and neuroinflammation.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Qin Q, Li M, Fan L, et al. RVG engineered extracellular vesicles-transmitted miR-137 improves autism by modulating glucose metabolism and neuroinflammation. Mol Psychiatry. 2025. PMID: 40175518. doi:10.1038/s41380-025-02988-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。